Menu
Back to User profile » Mr Mike Dolph
Papers published by Mr Mike Dolph:
Original Research
US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma
Dolph M, Tremblay G, Leong H
ClinicoEconomics and Outcomes Research 2021, 13:493-502
Published Date: 10 June 2021
Original Research
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A
ClinicoEconomics and Outcomes Research 2018, 10:715-721
Published Date: 5 November 2018
Original Research
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A
ClinicoEconomics and Outcomes Research 2018, 10:705-713
Published Date: 1 November 2018
Original Research
Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer
Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M
Cancer Management and Research 2018, 10:1319-1327
Published Date: 22 May 2018
Original Research
Systematic review of health state utility values for acute myeloid leukemia
Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G
ClinicoEconomics and Outcomes Research 2018, 10:83-92
Published Date: 25 January 2018